Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?

Andrea Di Cori, Alessio Lilli, Giulio Zucchelli, Valerio Zaca
  • Expert Review of Cardiovascular Therapy, February 2018, Taylor & Francis
  • DOI: 10.1080/14779072.2018.1438267
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Alessio Lilli and Dr Valerio Zacà

In partnership with: